Open Access. Powered by Scholars. Published by Universities.®

Medical Specialties Commons

Open Access. Powered by Scholars. Published by Universities.®

Oncology

Institution
Keyword
Publication Year
Publication
Publication Type
File Type

Articles 13921 - 13950 of 14285

Full-Text Articles in Medical Specialties

Oncolog, Volume 47, Number 05, May 2002, Kerry L. Wright, Ann Sutton, Carmelita Escalante Md May 2002

Oncolog, Volume 47, Number 05, May 2002, Kerry L. Wright, Ann Sutton, Carmelita Escalante Md

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Tobacco Research and Treatment Progra Studies Include Ways to Prevent and Treat Nicotine Dependence in Special Populations
  • Emergency Center Provides Specialized Care for M. D. Anderson Patients Experiencing Oncologic Emergencies
  • DiaLog: M. D. Anderson's Emergency Center, by Carmelita Escalante, MD, Associate Professor and Ad Interim Chair, Department of General Internal Medicine, Ambulatory Treatment, and Emergency Care
  • House Call: Depression and Cancer
  • Smoking Cessation Studies Blend Computer Technology with Behavioral Therapy


Clinical, Pathological And Molecular Factors Predicting Axillary Node Involvement In Primary Breast Cancer In Pakistani Women, T. Siddiqui, A. Salam, S. Khan, N. Kayani, Shahid Pervez May 2002

Clinical, Pathological And Molecular Factors Predicting Axillary Node Involvement In Primary Breast Cancer In Pakistani Women, T. Siddiqui, A. Salam, S. Khan, N. Kayani, Shahid Pervez

Department of Pathology and Laboratory Medicine

Background:

Axillary lymph node involvement in primary breast cancer is one of its most important prognostic features. Thus any factors that may predict axillary lymph node involvement in this setting could be potentially helpful in treatment planning and other interventions.

Objective:

The objective of this study was to evaluate clinical, pathological and immuno-histochemical markers in univariate and multivariate analysis, which may be helpful predictors of axillary lymph node involvement in breast cancer.

Method:

A retrospective analysis of 555 cases. Of these 58% had axillary nodal positivity and 42% were negative.

Conclusion:

Factors of no significance included patient’s age, height, weight, …


Role Of Disulphide Bond Formation In Folding, Secretion, And Assembly Of Human Chorionic Gonadotropin Subunits., Elliott Bedows, Ryan J. Darling, Jason A. Wilken, Simon Sherman Apr 2002

Role Of Disulphide Bond Formation In Folding, Secretion, And Assembly Of Human Chorionic Gonadotropin Subunits., Elliott Bedows, Ryan J. Darling, Jason A. Wilken, Simon Sherman

Journal Articles: Eppley Institute

Ability of a glycoprotein hormone to fold and assemble correctly is an essential requirement for the attainment of its biological activity . Cells have a quality control system to assure that when proteins of the endoplasmic reticulum mi sfold or fail to assemble correctly they do not exit the cell. But human chorionic gonadotropin (hCG) is an exception to this rule as is illustrated by the following observations. First, both hCG subunits are secreted efficiently as unassembled monomers. Second, some mis(un)folded forms of hCG-β can be efficiently secreted from cells that do not facilitate the secretion of other misfolded proteins. …


Oncolog, Volume 47, Number 04, April 2002, Beth Notzon, Karen Stuyck, Felipe Samaniego Md Apr 2002

Oncolog, Volume 47, Number 04, April 2002, Beth Notzon, Karen Stuyck, Felipe Samaniego Md

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Researchers Focus on Bioimmunotherap for Treatment of Non-Hodgkin's Lymphomas
  • Protocols: Non-Hodgkin's Lymphoma Studies
  • House Call: The First Cancer Prevention Vaccine
  • DiaLog: The Viral Origins of Lymphomas, by Felipe Samaniego, MD, Assistant Professor, Department of Lymphoma and Myeloma
  • Research Consortium Recruiting Volunteers to Study the Role of Genetics in Cancer Development and Patient Care


Mexican-Descent Latinas’ Compliance With Cervical Cancer Screening Guidelines, Evelinn A. Borrayo, Awilda Reyes Apr 2002

Mexican-Descent Latinas’ Compliance With Cervical Cancer Screening Guidelines, Evelinn A. Borrayo, Awilda Reyes

University Libraries Faculty Publications

No abstract provided.


Prostate Specific Membrane Antigen (Psma): Immunoassay Development And Characterization Of Transcriptional Regulation, Zhen Xiao Apr 2002

Prostate Specific Membrane Antigen (Psma): Immunoassay Development And Characterization Of Transcriptional Regulation, Zhen Xiao

Theses and Dissertations in Biomedical Sciences

Prostate cancer (PCA) is the most common cancer and the second leading cause of death among American men. The high mortality is greatly attributed to the lack of early detection tools and effective treatment for metastasis and relapses. Biomarkers that can discriminate benign from malignant tumor and signal the development of androgen independent and metastatic tumor are needed. A biomarker designated prostate specific membrane antigen (PSMA) has the potential to fulfill this need. The objective of this study is to develop a clinically useful immunoassay for quantitation of serum PSMA and to study the molecular mechanism underlying the upregulation of …


Siva-1 Binds To And Inhibits Bcl-Xl-Mediated Protection Against Uv Radiation-Induced Apoptosis, Li Xue, Fei Chu, Yuan Cheng, Xiangjie Sun, Alip Borthakur, Manjunath Ramarao, Pramod Pandey, Mei Wu, Stuart F. Schlossman, Kanteti V. S. Prasad Mar 2002

Siva-1 Binds To And Inhibits Bcl-Xl-Mediated Protection Against Uv Radiation-Induced Apoptosis, Li Xue, Fei Chu, Yuan Cheng, Xiangjie Sun, Alip Borthakur, Manjunath Ramarao, Pramod Pandey, Mei Wu, Stuart F. Schlossman, Kanteti V. S. Prasad

Clinical & Translational Sciences

We previously cloned Siva-1 by using the cytoplasmic tail of CD27, a member of the tumor necrosis factor receptor family, as the bait in the yeast two-hybrid system. The Siva gene is organized into four exons that code for the predominant full-length Siva-1 transcript, whereas its alternate splice form, Siva-2, lacks exon 2 coding sequence. Various groups have demonstrated a role for Siva-1 in several apoptotic pathways. Interestingly, the proapoptotic properties of Siva-1 are lacking in Siva-2. The fact that Siva-1 is partly localized to mitochondria despite the absence of any mitochondrial targeting signal, it harbors a 20-aa-long putative amphipathic …


Prevention Of Radiation-Induced Skin Reactions In Breast Cancer External Irradiation, Cathy Ammerman Mar 2002

Prevention Of Radiation-Induced Skin Reactions In Breast Cancer External Irradiation, Cathy Ammerman

Masters Theses & Specialist Projects

Radiation dermatitis is a common side effect of external beam radiation therapy. The purpose of this study was to evaluate the effectiveness of applying an aloe vera based skin gel to the target area skin in preventing the development of radiation dermatitis to postlumpectomy/ mastectomy patients receiving external beam radiation therapy in an ambulatory radiation-oncology clinic in the southeastern region of the United States. In this descriptive correlational study, a convenience sample of willing participants (n=18) was followed from initial treatment through the one-month follow-up examination to assess the intensity of their skin reaction. Five research questions were examined pertaining …


Oncolog, Volume 47, Number 03, March 2002, Vickie J. Williams, Michael Worley, Noelle Heinze, Richard J. Babaian Md Mar 2002

Oncolog, Volume 47, Number 03, March 2002, Vickie J. Williams, Michael Worley, Noelle Heinze, Richard J. Babaian Md

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Largest-Ever Cancer Prevention Study to Examine the Effects of Selenium and Vitamin E on Prostate Cancer Occurrence
  • Protocols: Prostate Cancer Clinical Trials
  • House Call: Understanding Metastasis
  • DiaLog: The Prostate--Specific Antigen Test: Reliability and Recommended Use, by Richard J. Babaian, MD, Professor, Department of Urology
  • Trouble Spots: Early Detection Is Key to the Successful Treatment of Melanoma


Epidermal Growth Factor Receptor (Egfr) As A Prognostic Marker: An Immunohistochemical Study On 315 Consecutive Breast Carcinoma Patients, S. A. Aziz, Shahid Pervez, N. Kayani, M. H. Rahbar, S. Khan Mar 2002

Epidermal Growth Factor Receptor (Egfr) As A Prognostic Marker: An Immunohistochemical Study On 315 Consecutive Breast Carcinoma Patients, S. A. Aziz, Shahid Pervez, N. Kayani, M. H. Rahbar, S. Khan

Department of Pathology and Laboratory Medicine

Objective: To assess the independent and interdependent prognostic value of epidermal growth factor receptor (EGFR) in carcinoma of breast in female population. The Type I family of growth factor receptors includes epidermal growth factor receptor (EGFR also known as EGFRI).

Methods: The expression of EGFR protein was analysed immunohistochemically on 315 tumour specimens of infiltrating ductal carcinoma of breast. These patients also had axillary lymph nodes sampling.

Results: Overexpression and/or amplification of EGFR was observed in 70 (22.00%) tumours. Eleven (16%) were grade I, 43 (61%) grade II and 16 (23%) grade Ill tumours. Axillary lymph node metastasis had significant …


Oncolog, Volume 47, Number 02, February 2002, Kerry L. Wright, Charles F. Leverbeck Md Feb 2002

Oncolog, Volume 47, Number 02, February 2002, Kerry L. Wright, Charles F. Leverbeck Md

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Molecular Therapies Target Bone Metastasis
  • "I'm Here to Help You" Patient Advocates Serve as Liaisons Between Patients and Care Centers
  • DiaLog: Patient Advocates: Solving Problems and Building Bridges, by Charles F. Leverback, MD, Associate Professor, Department of Gynecologic Oncology
  • House Call: Keeping the Heart Healthy in Patients with Cancer


2001 Cancer Care Annual Report, Children's Mercy Hospital Jan 2002

2001 Cancer Care Annual Report, Children's Mercy Hospital

Cancer Center Annual Reports

Annual report of cancer care and oncology services at the Children's Mercy Hospital, Kansas City MO, a pediatric medical center, with a focus on Wilms' Tumor.


Frequency Of Use Of Complementary And Alternative Medicine In Women With Breast Cancer, Cecile A. Lengacher, Mary Bennett, Kevin E. Kip, Rosemary Keller, Melisa S. Lavance, Lynette S. Smith, Charles E. Cox Jan 2002

Frequency Of Use Of Complementary And Alternative Medicine In Women With Breast Cancer, Cecile A. Lengacher, Mary Bennett, Kevin E. Kip, Rosemary Keller, Melisa S. Lavance, Lynette S. Smith, Charles E. Cox

Nursing Faculty Publications

No abstract provided.


Differential Synthesis Of Beta-Tubulin Isotypes In Gerbil Nasal Epithelia, Karen Woo, Heather Jensen Smith, Richard F. Ludueña, Richard Hallworth Jan 2002

Differential Synthesis Of Beta-Tubulin Isotypes In Gerbil Nasal Epithelia, Karen Woo, Heather Jensen Smith, Richard F. Ludueña, Richard Hallworth

Journal Articles: Eppley Institute

Compartmentalization of beta-tubulin isotypes within cells according to function was examined in gerbil olfactory and respiratory epithelia by using specific antibodies to four beta-tubulin isotypes (beta(I), beta(II), beta(III), and beta(IV)). Isotype synthesis was cell-type-specific, but the localization of the isotypes was not compartmentalized. All four isotypes were found in the cilia, dendrites, somata, and axons of olfactory neurons. Only two isotypes (beta(I) and beta(IV)) were present in the cilia of nasal respiratory epithelial cells. The beta(IV) isotype, thought to be an essential component of cilia, was present in olfactory neurons and respiratory epithelial cells, which are ciliated, but was not …


Il-12 Plasmid Delivery By In Vivo Electroporation For The Successful Treatment Of Established Subcutaneous B16.F10 Melanoma, M. Lee Lucus, Loree Heller, Domenico Coppola, Richard Heller Jan 2002

Il-12 Plasmid Delivery By In Vivo Electroporation For The Successful Treatment Of Established Subcutaneous B16.F10 Melanoma, M. Lee Lucus, Loree Heller, Domenico Coppola, Richard Heller

Bioelectrics Publications

Interleukin-12 (IL-12) has been used in numerous immunotherapy protocols against melanoma. However, delivery of IL-12 in the form of recombinant protein can result in severe toxicity, and gene therapy has had limited success against B16.F10 murine melanoma. The purpose of this study was to examine the effectiveness of in vivo electroporation for the delivery of plasmid DNA encoding IL-12 as an antitumor agent against B16.F10 melanoma. We treated mice bearing established B16.F10 melanoma tumors with intratumoral (i.t.) or intramuscular (i.m.) injections of a plasmid encoding IL-12, followed by in vivo electroporation. For i.t. treatments, we used an applicator containing six …


Oncolog, Volume 47, Number 01, January 2002, Dawn Chalaire, Mariann Crapanzano Jan 2002

Oncolog, Volume 47, Number 01, January 2002, Dawn Chalaire, Mariann Crapanzano

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Preserving and Restoring the Ability to Swallow in Patients with Head and Neck Cancer Requires a Team Approach
  • Modified Barium Swallow Helps Speech Pathologists Determine What Patients Are Able to Eat
  • House Call: Common Cancers, Common Symptoms
  • Portal Vein Embolization Offers More Pateints an Opportunity for Potentially Curative Hepatic Resection


The Role Of Diet And Physical Activity For Ovarian Cancer Results From The Adventist Health Study, Fatemeh Kiani Jan 2002

The Role Of Diet And Physical Activity For Ovarian Cancer Results From The Adventist Health Study, Fatemeh Kiani

Loma Linda University Electronic Theses, Dissertations & Projects

A few aspects of the epidemiology of ovarian cancer are well understood, such as the inverse relationship with parity and oral contraceptive (OC) use. The role of other factors such as the potential influence of diet or physical activity is far from being established. A few studies, however, have been able to identify dietary risk factors for ovarian cancer. In this dissertation, I have conducted two studies that investigate the relationship between dietary factors and physical activity and the three endpoints: 1) nonfatal ovarian cancer (1976-1982; time to diagnosis), 2) fatal ovarian cancer (1976-1988; time to death), and 3) total …


Psychological Impact Of Comprehensive Tumor Genomic Profiling Results For Advances Cancer Patients, Phyllis N. Butow, Megan Best, Grace Davies, Timothy Schlub, Christine Napier, Nicci Bartley, Mandy Ballinger, Ilona Juraskova, Bettina Meiser, David Goldstein, Barbara Biesecker, David Thomas Jan 2002

Psychological Impact Of Comprehensive Tumor Genomic Profiling Results For Advances Cancer Patients, Phyllis N. Butow, Megan Best, Grace Davies, Timothy Schlub, Christine Napier, Nicci Bartley, Mandy Ballinger, Ilona Juraskova, Bettina Meiser, David Goldstein, Barbara Biesecker, David Thomas

IES Papers and Journal Articles

Objective

Comprehensive tumor genomic profiling (CTGP) is increasingly used to personalize treatments, providing hope, but potentially disappointment, for patients. We explored psychological outcomes in patients with advanced, incurable cancer, after receiving CTGP results.

Methods

Participants with advanced, incurable cancer (n = 560, mean age 56, 43% university educated) in this longitudinal substudy of the Molecular Screening and Therapeutics Program (MoST), completed questionnaires before and after receiving CGP results. MoST participants, recruited from Australian oncology clinics, undergo CTGP, and if there are actionable findings, are offered treatment in a related therapeutic trial if available.

Results

Patients who received actionable results, (n …


Developing And Testing A Pain Management Program For Family Caregivers Of Advanced Cancer Patients, Lynn Oldham Jan 2002

Developing And Testing A Pain Management Program For Family Caregivers Of Advanced Cancer Patients, Lynn Oldham

Theses: Doctorates and Masters

Increasingly, advanced cancer patients are receiving care in the community supported by families and hospice home care services. However, little or no preparation is provided to family caregivers who assume this supportive role, often 24 hours per day. Pain management is consistently identified by family caregivers as their primary concern related to care and support of a relative with cancer. This project involved a three-phase program of research to develop and test a pain management program (PMP) that would provide family caregivers of advanced cancer patients with information and skills to manage the patient's pain.


Acute Myeloid Leukemia In Children In Pakistan: An Audit, S. Zaki, I. A. Burney, Mohammad Khurshid Jan 2002

Acute Myeloid Leukemia In Children In Pakistan: An Audit, S. Zaki, I. A. Burney, Mohammad Khurshid

Section of Haematology/Oncology

Objective: To see the clinical features and treatment of children with Acute Myeloid Leukemia (AML) in Pakistan. Setting: Tertiary referral at a specialist Hematology/Oncology center.
Methods: Retrospective, chart-based review of children (less than 14 years) admitted to the hospital with a diagnosis of AML between January 1987 and August 1997.
Results: A total of 23 patients were admitted. There were 18 males and 5 females. The mean age was 8 5 years. M3 was the commonest morphological subtype (43%). Twenty- two percent of the patients presented with hyperleucocytosis (TLC> 100 x i09 /L) and 95% with an elevated …


Lack Of Benefit Of Granulocyte Macrophage Or Granulocyte Colony Stimulating Factor In Patients With Febrile Neutropenia, T. Siddiqui, I. A. Burney, A. Salam, G. N. Kakepoto, Mohammad Khurshid, R. A. Smego Jan 2002

Lack Of Benefit Of Granulocyte Macrophage Or Granulocyte Colony Stimulating Factor In Patients With Febrile Neutropenia, T. Siddiqui, I. A. Burney, A. Salam, G. N. Kakepoto, Mohammad Khurshid, R. A. Smego

Section of Haematology/Oncology

Objectives: To compare the clinical benefits of granulocyte-colony stimulating factor (G-CSF) or granulocyte macrophage-colony stimulating factor (GM-CSF) plus standard supportive care to supportive care alone among cancer patients with febrile neutropenia.
Methods: Clinical data were collected retrospectively from 148 consecutive cancer patients with neutropenia and fever. Patients had hematologic (i.e., acute leukemias or lymphoproliferative disorders) or non-hematologic malignancies (i.e., solid tumors including carcinoma of breast, lung, or colon). Clinical variables analyzed included: age and sex; underlying malignancies; chemotherapy regimens; symptoms at time of presentation; duration of fever prior to study enrollment; days from chemotherapy until administration of GM-CSF or …


Oncolog, Volume 46, Number 11/12, November-December 2001, Karen Stuyck, Kerry L. Wright Nov 2001

Oncolog, Volume 46, Number 11/12, November-December 2001, Karen Stuyck, Kerry L. Wright

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Multidisciplinary Team Helps Patients with Cancer Overcome Cognitive Problems
  • Protocols: Studies Focus on Cognitive Effects of Cancer and Its Treatment
  • House Call: Simple Steps Can Put Patients on the Road to Well-Being
  • Highly Selective Synthetic Binding Agents Target Different DNA Conformations


Oncolog, Volume 46, Number 10, October 2001, Dawn Chalaire, Kerry L. Wright, Mary K. Hughes Ms, Rn Oct 2001

Oncolog, Volume 46, Number 10, October 2001, Dawn Chalaire, Kerry L. Wright, Mary K. Hughes Ms, Rn

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Surgical Techniques, New Agents Target Breast Disease with Increasing Accuracy
  • Undiagnosed Breast Clinic Provides Answers for Concerned Patients
  • House Call: Tips for Coping with the Cosmetic Effects of Breast Cancer
  • DiaLog: Breast Cancer and Body Image, by Mary K. Hughes, MS, RN, Department of Psychiatry
  • New Screening and Diagnostic Techniques Are Changing the Practice of Breast Imaging


Morphological Pattern Of Salivary Gland Tumours, M. S. Gill, S. Muzaffar, I. N. Soomro, Naila Kayani, A. S. Hussainy, Shahid Pervez, S. H. Hasan Oct 2001

Morphological Pattern Of Salivary Gland Tumours, M. S. Gill, S. Muzaffar, I. N. Soomro, Naila Kayani, A. S. Hussainy, Shahid Pervez, S. H. Hasan

Department of Pathology and Laboratory Medicine

Objective: To delineate the spectrum of salivary gland tumors in our setup.

Setting: The Aga Khan University Medical Centre, Karachi.

Method: Tumors were analysed considering histological type, age and sex of the patients and anatomic location. The diagnosis of individual tumours was based on the 1991 World Health Organisation Classification.

Results: During the span of eight years (1991-1998), 379 cases of salivary gland tumours were diagnosed. Of these, 205 (65.7%) were male and 174 (34.3%) were female. The median age at the time of diagnosis was 35 years. The median age for patients with malignant lesions (44 years) was 12 …


Therapeutic Electromagnetic Field Effects On Angiogenesis And Tumor Growth, C. Douglas Williams, Marko S. Markov, W. Elaine Hardman, Ivan L. Cameron Sep 2001

Therapeutic Electromagnetic Field Effects On Angiogenesis And Tumor Growth, C. Douglas Williams, Marko S. Markov, W. Elaine Hardman, Ivan L. Cameron

Biochemistry and Microbiology

Background: A new approach to cancer therapy based on the application of therapeutic electromagnetic fields (TEMF) has been developed by EMF Therapeutics, Inc., Chattanooga, TN, USA. This study was designed to assess the effect of TEMF on tumor vascularization and growth of murine 16/C mammmary adenocarcinoma cells in C3H/HeJ mice.

Materials and Methods: Implanted tumors were allowed to grow for seven days until the tumor volume reached 100 mm3 before treatment was started. Mice (20 per control, 10 per EMF exposed group) received treatment (10 minutes per day with 0, 10 mT, 15 mT or 20 mT) with a 120 …


Oncolog, Volume 46, Number 09, September 2001, Beth Notzon, Kerry L. Wright, Renato Lenzi Md Sep 2001

Oncolog, Volume 46, Number 09, September 2001, Beth Notzon, Kerry L. Wright, Renato Lenzi Md

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Completing the Job: Multidisciplinary Effort Restores Form and Function, Improves Patients' Quality of Life
  • House Call: Denial and Cancer
  • Protocols: Studies Examine Treatments for Glioma
  • DiaLog: Addressing the Problem of Patients' Denial, by Renato Lenzi, MD, Associate Professor, Department of Gastrointestinal Medical Oncology
  • New Replication-Competent Adenovirus Shows Promise against Gliomas in Preclinical Studies


Oncolog, Volume 46, Number 07/08, July/August 2001, Mariann Crapanzano, Noelle Heinze, Wendeline Jongenberger Mba Jul 2001

Oncolog, Volume 46, Number 07/08, July/August 2001, Mariann Crapanzano, Noelle Heinze, Wendeline Jongenberger Mba

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Chemoprevention Researchers Look for Ways to Halt the Process of Carcinogenesis
  • House Call: HPV and Cancer: What Every Woman--and Man--Should Know
  • Chemoprevention Trial Targets Former Smokers
  • DiaLog: Serving International Clients, by Wendeline Jongenberger, MBA, Director, International Programs
  • Protocols: Chemoprevention Clinical Trials


Oncolog, Volume 46, Number 06, June 2001, Kathryn Hale, Dawn Chalaire Jun 2001

Oncolog, Volume 46, Number 06, June 2001, Kathryn Hale, Dawn Chalaire

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Bladder Cancer Genetic Mapping Effort Builds on Human Genome Project
  • Protocols: Clinical Trials for Bladder Cancer
  • Keeping in Touch: Office of Physician Relations Builds Partnerships, Maintains Contact with Community Physicians
  • House Call: Overcoming Barriers to Cancer Screening for Men


Oncolog, Volume 46, Number 05, May 2001, Kate O'Suilleabhain, Roy S. Herbst Md, Phd, Kerry L. Wright May 2001

Oncolog, Volume 46, Number 05, May 2001, Kate O'Suilleabhain, Roy S. Herbst Md, Phd, Kerry L. Wright

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Antiangiogenic Agents: Changing the Nature of Cancer Treatment
  • DiaLog: Angiogenesis Research: Looking for New Ways to Measure Success, by Roy S. Herbst, MD, PhD, Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology
  • House Call: Overcome Fears of Cancer Recurrence by Taking Action
  • Recognition Spurs Prevention of Osteoporosis in Patients with Cancer
  • Protocols: Clinical Trials of Antiangiogenic Agents


Oncolog, Volume 46, Number 04, April 2001, Kerry L. Wright, Don Norwood, Dawn Chalaire, Julie Penne Apr 2001

Oncolog, Volume 46, Number 04, April 2001, Kerry L. Wright, Don Norwood, Dawn Chalaire, Julie Penne

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Clinical PET Facility Returns to M.D. Anderson
  • Trial Shows Pill Is as Effective as Intravenous Chemotherapy for Advanced Colon Cancer
  • House Call: After Cancer: A Survivor's Diary
  • Postirradiation Oral Complications Are Serious but Preventable